FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Greenstone methylprednisolone tablets Recall

methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21…

Greenstone Llc · Peapack, NJ

Risk level
Class II
Reported by FDA
Feb 4, 2026
Recall ID
D-0299-2026
Check your lot numberHow we source this data

Summary

Greenstone recalled methylprednisolone tablets starting Jan 15, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0299-2026 on Feb 4, 2026. Reason: Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil. Status: Ongoing.

Why it was recalled

Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.

Product description

methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2

Lot numbers, UPCs & expiration codes

Lot # LG7675, Exp. Date Nov 2026

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0299-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jan 15, 2026
FDA report date
Feb 4, 2026
Quantity
3456 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Greenstone Llc

Original FDA data

Every field from FDA enforcement report D-0299-2026, exactly as published.

Show all FDA fields
City
Peapack
State
NJ
Status
Ongoing
Country
United States
Event ID
98278
Address
100 Route 206 North
Code information
Lot # LG7675, Exp. Date Nov 2026
Postal code
07977
Report date
Feb 4, 2026
Product type
Drugs
Recall number
D-0299-2026
Classification
Class II
Recalling firm
Greenstone Llc
Product quantity
3456 cartons
Reason for recall
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Voluntary / mandated
Voluntary: Firm initiated
Product description
methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2
Distribution pattern
Nationwide within the United States
Recall initiation date
Jan 15, 2026
Initial firm notification
Letter
Center classification date
Jan 28, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0299-2026, published Feb 4, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls